Issue Date: November 5, 2012
Old Tuberculosis Treatment Performs As Prodrug
A 60-year-old tuberculosis drug, p-aminosalicylic acid (PAS), acts as a prodrug rather than by inhibiting a key bacterial enzyme directly, according to a research report (Science, DOI: 10.1126/science.1228980).
PAS and other drugs of its era “have been around for a long time, and we really don’t know how they work,” says Stephen White, a professor of structural biology . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society